# Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn

> **NCT00389948** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 576 (—)

## Conditions studied

- Heartburn

## Interventions

- **DRUG:** Lanzoprazole

## Key facts

- **NCT ID:** NCT00389948
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 576 (—)
- **Last updated:** 2007-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389948, "Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00389948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*